These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 9259327

  • 1. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G, Ediger TR, Petz LN, Nardulli AM, Katzenellenbogen BS.
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [Abstract] [Full Text] [Related]

  • 2. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
    Weis KE, Ekena K, Thomas JA, Lazennec G, Katzenellenbogen BS.
    Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
    [Abstract] [Full Text] [Related]

  • 3. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
    Bai Y, Giguére V.
    Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
    [Abstract] [Full Text] [Related]

  • 4. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators.
    Lopez GN, Webb P, Shinsako JH, Baxter JD, Greene GL, Kushner PJ.
    Mol Endocrinol; 1999 Jun; 13(6):897-909. PubMed ID: 10379889
    [Abstract] [Full Text] [Related]

  • 5. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.
    Carlson KE, Choi I, Gee A, Katzenellenbogen BS, Katzenellenbogen JA.
    Biochemistry; 1997 Dec 02; 36(48):14897-905. PubMed ID: 9398213
    [Abstract] [Full Text] [Related]

  • 6. Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain.
    Eng FC, Barsalou A, Akutsu N, Mercier I, Zechel C, Mader S, White JH.
    J Biol Chem; 1998 Oct 23; 273(43):28371-7. PubMed ID: 9774463
    [Abstract] [Full Text] [Related]

  • 7. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
    Klinge CM, Jernigan SC, Mattingly KA, Risinger KE, Zhang J.
    J Mol Endocrinol; 2004 Oct 23; 33(2):387-410. PubMed ID: 15525597
    [Abstract] [Full Text] [Related]

  • 8. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
    Dutertre M, Smith CL.
    Mol Endocrinol; 2003 Jul 23; 17(7):1296-314. PubMed ID: 12714702
    [Abstract] [Full Text] [Related]

  • 9. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
    Fleming FJ, Hill AD, McDermott EW, O'Higgins NJ, Young LS.
    J Clin Endocrinol Metab; 2004 Jan 23; 89(1):375-83. PubMed ID: 14715875
    [Abstract] [Full Text] [Related]

  • 10. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY, Ito M, Park Y, Tagami T, Gehm BD, Jameson JL.
    Mol Endocrinol; 1999 Dec 23; 13(12):2122-36. PubMed ID: 10598586
    [Abstract] [Full Text] [Related]

  • 11. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
    Pakdel F, Reese JC, Katzenellenbogen BS.
    Mol Endocrinol; 1993 Nov 23; 7(11):1408-17. PubMed ID: 8114756
    [Abstract] [Full Text] [Related]

  • 12. Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins.
    Schaufele F.
    Mol Endocrinol; 1999 Jun 23; 13(6):935-45. PubMed ID: 10379892
    [Abstract] [Full Text] [Related]

  • 13. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC, Carlson KE, Martini PG, Katzenellenbogen BS, Katzenellenbogen JA.
    Mol Endocrinol; 1999 Nov 23; 13(11):1912-23. PubMed ID: 10551784
    [Abstract] [Full Text] [Related]

  • 14. Effect of ligand and DNA binding on the interaction between human transcription intermediary factor 1alpha and estrogen receptors.
    Thénot S, Bonnet S, Boulahtouf A, Margeat E, Royer CA, Borgna JL, Cavaillès V.
    Mol Endocrinol; 1999 Dec 23; 13(12):2137-50. PubMed ID: 10598587
    [Abstract] [Full Text] [Related]

  • 15. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
    Métivier R, Penot G, Flouriot G, Pakdel F.
    Mol Endocrinol; 2001 Nov 23; 15(11):1953-70. PubMed ID: 11682626
    [Abstract] [Full Text] [Related]

  • 16. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
    Shah YM, Rowan BG.
    Mol Endocrinol; 2005 Mar 23; 19(3):732-48. PubMed ID: 15528270
    [Abstract] [Full Text] [Related]

  • 17. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements.
    Hall JM, McDonnell DP, Korach KS.
    Mol Endocrinol; 2002 Mar 23; 16(3):469-86. PubMed ID: 11875105
    [Abstract] [Full Text] [Related]

  • 18. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS.
    Mol Endocrinol; 1996 Mar 23; 10(3):230-42. PubMed ID: 8833652
    [Abstract] [Full Text] [Related]

  • 19. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
    Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS.
    Endocrinology; 2000 Oct 23; 141(10):3534-45. PubMed ID: 11014206
    [Abstract] [Full Text] [Related]

  • 20. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J, Liu H, Bentrem DJ, Zapf JW, Jordan VC.
    Cancer Res; 2000 Sep 15; 60(18):5097-105. PubMed ID: 11016635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.